The Column Group Email Format
Venture Capital and Private Equity PrincipalsCalifornia, United States11-50 Employees
The Column Group is a San Francisco-based venture capital and private equity firm operating in the life sciences sector. It concentrates substantial resource commitments and hands-on support to develop early-stage drug-discovery companies built around unique scientific platforms with the potential to yield multiple therapeutics. Unlike funds that pursue diversified, late-stage, single-product bets, The Column Group takes a long view and seeks to cultivate fundamentally strong companies rooted in scientific opportunity rather than quick exits. The firm combines scientific insight with strategic oversight and operational know-how to translate promising science into entities that could advance human health. Its approach favors focus over diversification, directing access to ideas, founders, and top-tier talent within a small cohort of ventures. In 2024, The Column Group expanded its leadership with the appointment of Arnav Mehta as venture partner.